Literature DB >> 6132884

P-fimbriae of pyelonephritogenic Escherichia coli: detection in clinical material by a rapid receptor-specific agglutination test.

R Möllby, G Källenius, T K Korhonen, J Winberg, S B Svenson.   

Abstract

A slide agglutination test to detect P-fimbriated Escherichia coli was developed by attaching glycosides containing the relevant receptor structure (alpha-D-Galp-(1-4)-beta-D-Galp) to particles. A suspension of these particles agglutinates within ten seconds when mixed with P-fimbriated bacteria. The test is named the P-specific particle agglutination test (PPA test). The PPA test is more sensitive than the haemagglutination assays previously used. The exclusive specificity of the PPA test also allows the detection of P-fimbriae on strains which additionally possess other fimbriae (e.g. X-fimbriae). Using this test, the frequency of P-fimbriated E. coli in children with acute non-obstructive pyelonephritis was shown to exceed 95%. In lower urinary tract infections the frequency of P-fimbriated E. coli was approximately 20%. Moreover, children with acute pyelonephritis were also found to be heavily colonized in both the periurethral area and the intestine with the identical P-fimbriated E. coli strain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132884     DOI: 10.1007/bf01651363

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

Review 1.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

2.  Carbohydrate receptor structures recognized by uropathogenic E. coli.

Authors:  G Källenius; S B Svenson; R Möllby; T Korhonen; J Winberg; B Cedergren; I Helin; H Hultberg
Journal:  Scand J Infect Dis Suppl       Date:  1982

3.  P-antigen-recognizing fimbriae from human uropathogenic Escherichia coli strains.

Authors:  T K Korhonen; V Väisänen; H Saxén; H Hultberg; S B Svenson
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

4.  Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli.

Authors:  G Källenius; S Svenson; R Möllby; B Cedergren; H Hultberg; J Winberg
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

5.  THE EPIDEMIOLOGY OF NONENTERIC ESCHERICHIA COLI INFECTIONS. II. RELATIONSHIP OF PREVALENCE OF E. COLI IN URINARY INFECTIONS TO THE BACTERICIDAL EFFECT OF HUMAN SERUM.

Authors:  H KIMBALL; M GARCIA; R G PETERSDORF
Journal:  J Lab Clin Med       Date:  1964-06

6.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

7.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

8.  P-fimbriae of pyelonephritogenic Escherichia coli: significance for reflux and renal scarring-a hypothesis.

Authors:  G Källenius; S B Svenson; H Hultberg; R Möllby; J Winberg; J A Roberts
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

9.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

10.  In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells.

Authors:  G Källenius; R Möllby; J Winberg
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  1 in total

Review 1.  P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors.

Authors:  S B Svenson; H Hultberg; G Källenius; T K Korhonen; R Möllby; J Winberg
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.